
Angela is a Principal with ZS Associates' Philadelphia, and the global leader of ZS's sales and marketing effectiveness practice. Since joining ZS in 1999, she has developed frameworks and methodologies to help clients optimize selling productivity, design and implement innovative customer interaction models, and optimize the success of product launches.
Angela's assignments have included work in the United States, Canada, Western and Central Europe, Australia, China and Japan. Angela is a frequent guest speaker on sales and marketing effectiveness at conferences and in educational seminars.
Angela is a Marshall Scholar and has a PhD in Immunology. She also holds an A.B in English with honors from Stanford University where she graduated Phi Beta Kappa.
Most pharma companies have embarked on key account management (KAM) initiatives in one way or another. But building a true KAM competency can be a costly proposition. And in an environment where so many organizations are cutting costs, pharmaceutical executives need to ask some tough questions: How exactly do we create new value through KAM? Are we there yet?
(Dec 21, 2009)Kevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs